- H.
Lundbeck A/S,
commonly referred to as
Lundbeck, is a
Danish international pharmaceutical company engaged in the research, development, manufacturing...
- The
Brain Prize,
formerly known as The
Grete Lundbeck European Brain Research Prize, is an
international scientific award honouring "one or more scientists...
- at
Lundbeck; in 2007
Lundbeck and
Takeda entered into a
partnership that
included tedatioxetine but was
focused on another, more
advanced Lundbeck drug...
-
William Lundbeck (16
October 1863 in
Aalborg – 18 May 1941 in
Kongens Lyngby) was a
Danish entomologist mainly interested in Diptera. He was a Professor...
- name: escitalopram.
Escitalopram was
developed in
cooperation between Lundbeck and
Forest Laboratories. Its
development was
initiated in 1997, and the...
- was in
Phase II
clinical trials, and
Lundbeck and
Takeda entered into a
partnership in
which Takeda paid
Lundbeck $40
million up-front, with
promises of...
-
resulting in a
series of
clinical trials sponsored by
Lundbeck and Merck. In
March 2007,
Merck and
Lundbeck cancelled work on the drug,
citing safety concerns...
-
pharmaceutical company Lundbeck, plus a
total of €52.2 million on
several generic pharmaceutical-producing companies. This was in
response to
Lundbeck entering an...
- (both
somnolence and insomnia).
Brexpiprazole was
developed by Ot**** and
Lundbeck, and is
considered to be a
successor to
aripiprazole (Abilify). It was...
- Cymbalta" (PDF).
Fraende M (April 22, 2011). "
Lundbeck gets
Lexapro approval in ****an". Reuters. "Takeda and
Lundbeck Submit New Drug
Application (NDA) for Vortioxetine...
